MET and adrenal cortex carcinoma: Moreover, an in vivo experiment in a mouse model confirmed that the knockout of c-MET inhibited adrenocortical carcinoma growth, tumour-related angiogenesis, chemotherapy resistance and cell survival, further suggesting this molecular pathway as a valuable therapeutic target for adrenocortical carcinoma [69].